Milestone Scientific Inc. (MLSS) stock
MLSSNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 7/309% below fair value
$0.29−0.02 (-6.36%)
Close on Nov 12, 2026Market cap $25.73MP/E –Yield –
Milestone Scientific ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Milestone Scientific's ebitda for the twelve months ending Jun 30, 2026 was -$4.03M. For fiscal 2025 it was -$5.62M. The highest annual figure on record is -$3.90M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.62M | – |
| FY2024 | Dec 31, 2024 | -$6.72M | – |
| FY2023 | Dec 31, 2023 | -$7.04M | – |
| FY2022 | Dec 31, 2022 | -$8.76M | – |
| FY2021 | Dec 31, 2021 | -$7.30M | – |
| FY2020 | Dec 31, 2020 | -$7.36M | – |
| FY2019 | Dec 31, 2019 | -$3.90M | – |
| FY2018 | Dec 31, 2018 | -$7.12M | – |
| FY2017 | Dec 31, 2017 | -$4.66M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.04M | – |
| Q1 FY2026 | Mar 31, 2026 | -$808.63K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.06M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.11M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.47M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.03M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.77M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.45M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.97M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.26M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.33M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.00M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.00M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.87M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.90M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.52M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.96M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.86M | – |
| Q1 FY2021 | Mar 31, 2021 | -$963.45K | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.17M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.46M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.15M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.57M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.10M | -142746.2% |
| Q3 FY2019 | Sep 30, 2019 | -$921.32K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.08M | – |
| Q1 FY2019 | Mar 31, 2019 | -$792.14K | – |
| Q4 FY2018 | Dec 31, 2018 | $773 | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.20M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.18M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.74M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.40M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.25M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.52M | – |
| Q1 FY2017 | Mar 31, 2017 | -$491.39K | – |
See a number that looks wrong?